1)soluble thrombomodulin可溶性血栓调节蛋白
1.Objective: To investigate clinical therapeutic effect of modified Qianjin Weijing decoction(加味千金苇茎汤) on acute aggravated stage of cor pulmonale and its effect on soluble thrombomodulin(sTM).目的:观察加味千金苇茎汤对慢性肺源性心脏病(肺心病)急性加重期患者的临床疗效以及对可溶性血栓调节蛋白(sTM)的影响。
2)plasma soluble thrombomodulin血浆可溶性血栓调节蛋白
1.Objective To elucidate relationship between plasma soluble thrombomodulin (sTM) and small vascular injury and atherothrombosis in patients with atherothrombotic cerebral infarction and cerebral hemorrhage.目的探讨血浆可溶性血栓调节蛋白(Solublethrombmodulin,sTM)与脑梗塞和脑出血患者小血管损伤、动脉粥样硬化的关系。
3)thrombomodulin血栓调节蛋白
1.Relationship Study of Diabetic Nephropathy with Von Willebrand Factor and Thrombomodulin;血管性假血友病因子、血栓调节蛋白与糖尿病肾病的关系研究
2.Relation of methylation of plasma thrombomodulin gene promoter and coronary heart disease;冠心病与血浆血栓调节蛋白基因启动子甲基化有关
3.Effects of Polysaccharide Sulfate on plasma von Willebrand factor and thrombomodulin in patients with acute cerebral infarction;藻酸双酯钠对急性脑梗死患者血浆血管性假血友病因子和血栓调节蛋白的影响
英文短句/例句
1.The Clinical Significance of Thrombomodulin in Kawasaki Disease;血栓调节蛋白在川崎病中的临床意义
2.Expression of thrombomodulin in mammary carcinoma血栓调节蛋白在乳腺癌组织中的表达
3.Study on Dynamic Variation of Thrombomodulin in Patients with Cerebral Hemorrhage;脑出血患者血栓调节蛋白动态变化研究
4.Effect of C5a with the Thrombomodulin Expression on Endothelial Cells in VitroC5a对血管内皮细胞表达血栓调节蛋白的影响
5.Changes and Significance of Thrombomodulin in Patients with Acute Myocardial Infarction Who Had Thrombolytic Therapy;急性心肌梗死溶栓患者血浆血栓调节蛋白浓度变化及意义
6.Study on the relationship between TM and carotid artery lesion in diabetic rats糖尿病大鼠血栓调节蛋白与颈动脉病变的关系
7.Design and Study of the Primers of Thrombomodulin in Rat大鼠血栓调节蛋白基因引物的设计与研究
8.Changes of Histochemical Pathology and Thrombomodulin in Arterial Microembolisation;动脉微栓塞组织病理及血栓调节蛋白变化的实验研究
9.The Relationship between Thrombomodulin, High Sensitive C-Reactive Protein and the Ischemic Events of Coronary Artery Disease;血栓调节蛋白、高敏C反应蛋白与冠心病急性事件的关系
10.Study on the Dependablity between TM, APCR and Cerebral Infarction血栓调节蛋白、活化蛋白C抵抗与脑梗死的相关性研究
11.Preliminary Study on the Relationship between the Methylation of Plasma Thrombomodulin Gene Promoter and CHD;冠心病与血浆血栓调节蛋白基因启动子甲基化关系的初步研究
12.The Change and Clinical Significance of Serum Thrombomodulin in Diabetic Nephropathy;糖尿病肾病患者血清血栓调节蛋白的变化及临床意义
13.The Study on Detection of the Plasma Levels of TM in Patients with Unstable Angina Pectoris;不稳定心绞痛患者血浆中血栓调节蛋白的测定及临床意义的研究
14.Determination of plasma levels of thrombomodulin and its significance in children with henoch-schonlein purpura过敏性紫癜患儿血浆中血栓调节蛋白水平的测定及意义
15.The change of plasma thrombomodulin and D-dimer in patients with acute pancreatitis急性胰腺炎病人血浆血栓调节蛋白、D-二聚体变化的研究
16.Study on the Levels of Plasma Thrombomodulin in Patients of Diabetic Retinopathy糖尿病视网膜病变患者血浆血栓调节蛋白水平研究
17.Effects of Shear Stress on Protein C Activation,EPCR Expression And TM Expression in Endothelial Cells流体剪应力对内皮细胞蛋白C的活化以及蛋白C受体和血栓调节蛋白表达的影响(英文)
18.The Correlution of TM、TNFα、VEGF in the Pathology of Mesangial Proliferative Glomerulo Nephritis;血栓调节蛋白、TNFα、VEGF在系膜增生性肾小球肾炎中的相关研究
相关短句/例句
plasma soluble thrombomodulin血浆可溶性血栓调节蛋白
1.Objective To elucidate relationship between plasma soluble thrombomodulin (sTM) and small vascular injury and atherothrombosis in patients with atherothrombotic cerebral infarction and cerebral hemorrhage.目的探讨血浆可溶性血栓调节蛋白(Solublethrombmodulin,sTM)与脑梗塞和脑出血患者小血管损伤、动脉粥样硬化的关系。
3)thrombomodulin血栓调节蛋白
1.Relationship Study of Diabetic Nephropathy with Von Willebrand Factor and Thrombomodulin;血管性假血友病因子、血栓调节蛋白与糖尿病肾病的关系研究
2.Relation of methylation of plasma thrombomodulin gene promoter and coronary heart disease;冠心病与血浆血栓调节蛋白基因启动子甲基化有关
3.Effects of Polysaccharide Sulfate on plasma von Willebrand factor and thrombomodulin in patients with acute cerebral infarction;藻酸双酯钠对急性脑梗死患者血浆血管性假血友病因子和血栓调节蛋白的影响
4)Thromobomdulin血栓调节蛋白TM
5)human thrombomodulin人血栓调节蛋白
1.The construction of eukaryotic expression plasmid for human thrombomodulin gene;人血栓调节蛋白基因真核表达质粒的构建
2.It is supposed that overexpression of human anticoagulants such as human thrombomodulin(hTM) in a transplanted xenograft might significantly prolong the graft survival.用 PCR方法从人的基因组 DNA中扩增了人血栓调节蛋白 (h TM)基因 ,将其克隆到带有人 EF- 1α启动子的p EF- neo哺乳动物表达载体上 ,得到表达质粒 p EF- TM。
3.Objective To construct eukaryotic expression plasmid containing human thrombomodulin gene for further study on hTM characteristic in anticoagulant, antiflammatory and neointima formation resistant.第一部分 含血栓调节蛋白基因真核表达质粒的构建 目的 构建人血栓调节蛋白(human thrombomodulin,hTM)基因的真核表达质粒,为研究hTM基因在抗血栓、抗炎症、抗血管内膜增生等方面的作用及其临床应用奠定物质基础。
6)plasma thromobomodulin血浆血栓调节蛋白
1.Objective To study clinical significance and levels of plasma thromobomodulin (PTM)in two kind of malignant hematological diseases leukemia and myloma.目的 研究二种恶性血液病白血病和骨髓瘤患者血浆血栓调节蛋白 (PTM)的水平及临床意义。
延伸阅读
普通免疫球蛋白 ,人血丙种球蛋白,丙种球蛋白药物名称:丙种球蛋白英文名:γ-Globulin别名: 免疫血清球蛋白;普通免疫球蛋白 ,人血丙种球蛋白,丙种球蛋白外文名:γ-Globulin 适应症: 含有健康人群血清所具有的各种抗体,因而有增强机体抵抗力以预防感染的作用。主要用于免疫缺陷病以及传染性肝炎、麻疹、水痘、腮腺炎、带状皰疹等病毒感染和细菌感染的防治,也可用于哮喘、过敏性鼻炎、湿疹等内源性过敏性疾病。 用量用法: 肌注:每次2~5ml,3周1次,用于内源性过敏性疾病,每次10ml(含量10%者),3周内注射2次。胎盘球蛋白每次6~9ml。 注意事项: 1.按球蛋白来源可分为两种,一为健康人静脉血来源的丙种球蛋白制剂,按蛋白质含量有10%、16%、16.5%等数种(国内制品浓度在10%以上),其中丙种球蛋白占95%以上。另一种为胎盘血来源的丙种球蛋白(人胎盘血丙种球蛋白),即胎盘球蛋白,含蛋白质5%,其中丙种球蛋白占90%以上。胎盘球蛋白因丙种球蛋白含量以及纯度均较低,其用量应相应增大。 2.除专供静注用的制剂外,一般制剂不可静注。 3.注射大量时,可见局部疼痛和暂时性体温升高。 注:参见:“丙种球蛋白注射液”. 类别:免疫增强剂(免疫反应调节剂)